Featured
Newly diagnosed ovarian cancer patients can now have access to cancer delaying drug, Olaparib. Before this, only advanced ovarian cancer patients take Olaparib in later stages of treatment. NICE, The National Institute for Health and Care Excellence approved the use...
read more
Discovering the cure for malignant mesothelioma is very important. And doctors are using radical approaches in the currently approved radiotherapy, chemotherapy, and surgical treatments. Simultaneously, finding the mechanism with which tumor cells progress and...
read more
A recent oncology study has shown that delivering Oxaliplatin through a new spray-on technique may increase in the survival of advanced peritoneal mesothelioma with few side effects. Oncologists from France, Saudi Arabia, and Switzerland studied the effectiveness of...
read more
A federal judge will rule next week on what evidence will be admitted in ongoing lawsuits against Johnson & Johnson (J&J) alleging that asbestos in the company’s talc-based products has caused ovarian cancer and mesothelioma. The outcome of the hearing in a...
read more
Chemotherapy with Niraparib can extend the life of ovarian cancer patients who have already undergone 4 or more chemotherapy treatments. American researchers give hope to ovarian cancer patients who have undergone several rounds of chemotherapy treatment and have lost...
read more
New dimensions in radiotherapy are paving the way to strategize pleural mesothelioma treatment. Changes in the fractionation of radiation dosage, use of Stereotactic Body Radiation Therapy- SBRT as salvage therapy and combining radiotherapy with immunotherapy are few...
read more
Avelumab Treatment can restrict the tumor progression in mesothelioma patients who have previously received chemotherapy. This treatment is safe to use as second-line therapy for mesothelioma. Researchers from the National Cancer Institute, National Institute of...
read more
Chinese researchers observed that DFMO (a-difluoromethylornithine) treatment could significantly restrict the tumor growth in resectable malignant pleural mesothelioma (MPM) patients who have undergone U.S. FDA approved chemotherapeutic treatment. DFMO treatment...
read more
French researchers found that BDNF- Brain-derived neurotrophic factor is linked with the start and spread of the tumor in malignant pleural mesothelioma. Additional research can improve diagnosis and mesothelioma treatment.
read more
Researchers revealed that excessive genital use of talcum powder changes the enzymatic activity favoring ovarian cancer cells' survival. Moreover, with changes at the molecular level, it also causes a reduction in ovarian cancer cell death (apoptosis) and increases in...
read more